Endogenous control of inflammatory visceral pain by T cell-derived opioids in IL-10-deficient mice.
Lilian BassoMehdi BenamarXavier Mas-OreaCéline DeraisonCatherine BlanpiedNicolas CenacAbdelhadi SaoudiGilles DietrichPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2019)
Opioid-mediated analgesic activity of mucosal T lymphocytes remains operating in IL-10-/- mice with impaired immune regulation. The data suggest that endogenous T cell-derived opioids might reduce inflammation-induced abdominal pain in inflammatory bowel diseases associated with homozygous "loss of function mutations" in interleukin-10.